1 Simple Reason to Buy NuScale Power (SMR) Right Now

NuScale Power’s stock is down over 80% from its Oct. 15, 2025 peak of $53.43, trading under $10, as deployment of its SMR reactors is delayed until the early 2030s. Analysts still project revenue rising from $31M in 2025 to $311M by 2028 (driven by FEED studies, licensing and consulting) before commercial deployments begin. The article frames the setup as speculative but potentially attractive for long-term investors if revenue/profit accelerate in the 2030s once reactors come online.

Analysis

SMR is still being valued like a pre-commercial platform option, but the market is underestimating how long that option can remain out of the money. The near-term tape will likely be driven less by reactor economics and more by financing risk, dilution, and whether headline project wins convert into durable backlog; that argues for sharp rallies to fade unless accompanied by a material balance-sheet derisking event.

The cleaner beneficiary is FLR, which monetizes the buildout before SMR does. If even a fraction of the announced pipeline survives schedule and permitting friction, FLR captures engineering/procurement revenue now while SMR absorbs the capital intensity and execution risk later. Second-order, any renewed enthusiasm for SMRs could lift the broader nuclear supply chain, but the first-order cash flow is likely to accrue to contractors, regulators, and fuel-cycle names long before it shows up in SMR’s P&L.

The contrarian miss is duration: investors are anchoring on a 2030s commercialization story while ignoring the probability-weighted path between here and then. A 10x sales multiple on a still-unprofitable company with long lead times is not cheap if the base case requires multiple equity raises or schedule slippage. The thesis fails if SMR secures large, non-dilutive project financing or if a major utility commits to firm-offtake terms that visibly de-risk the first deployments within the next 6-12 months.

Key Decisions for Investors

• Prefer FLR over SMR on a 6-18 month horizon: long FLR / short SMR as a relative-value expression of nuclear buildout optionality. FLR should monetize design and construction before SMR monetizes reactors; risk is a sudden SMR financing breakthrough.
• Do not chase SMR on narrative alone; wait for an equity raise, project-financing update, or binding EPC milestone before considering a long entry. Until then, the stock is exposed to dilution and schedule reset risk.
• If you want nuclear exposure, use a basket/sector proxy rather than single-name SMR risk. The cleaner trade is long the picks-and-shovels beneficiaries, not the most speculative commercialization vehicle.
• Set a catalyst alert for any disclosed capital plan or DOE/utility financing support over the next 1-3 months. That is the first credible inflection point; absent it, the risk/reward favors fading strength rather than buying weakness.